Clinical Trial Update: Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a monoclonal antibody for treating acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Monoclonal antibody (unnamed)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Leukemia | Phase 2 | Status: UNKNOWN